Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric D Marsh

Showing results (101-110 of 156) with videos related to

Pageof 16
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 22, 2026
Therapeutic suppression of Tubb4a rescues H-ABC leukodystrophySunetra Sase, Julia L Hacker, Prabhat R Napit, et al.
Epilepsia|November 11, 2023
Long-term treatment with ganaxolone for seizures associated with cyclin-dependent kinase-like 5 deficiency disorder: Two-year open-label extension follow-upHeather E Olson, Sam Amin, Nadia Bahi-Buisson, et al.
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|July 4, 2024
Modification of a parent-report sleep scale for individuals with CDKL5 deficiency disorder: a psychometric studyJacinta M Saldaris, Scott Demarest, Peter Jacoby, et al.
Epilepsy Research|April 26, 2019
Long-term safety and efficacy of cannabidiol in children and adults with treatment resistant Lennox-Gastaut syndrome or Dravet syndrome: Expanded access program resultsLinda C Laux, E Martina Bebin, Daniel Checketts, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|September 9, 2025
Parent/caregiver perspectives of meaningful improvement in functional domains for people with CDKL5 deficiency disorder: a mixed-methods studyJessica Keeley, Zoe Skoda, Karen Utley, et al.
Brain and Behavior|November 14, 2025
Beyond Seizures as an Outcome Measure: A Global Severity Scoring System for CDKL5 Deficiency DisorderPeter Jacoby, Eric D Marsh, Scott Demarest, et al.
Elife|February 18, 2026
Impaired excitability of fast-spiking neurons in a novel mouse model of <i>KCNC1</i> epileptic encephalopathyEric R Wengert, Sophie R Liebergall, Teresa Jimenez, et al.
American Journal of Medical Genetics. Part A|March 22, 2021
Understanding the phenotypic spectrum of ASXL-related disease: Ten cases and a review of the literatureVishnu Anand Cuddapah, Holly A Dubbs, Laura Adang, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|August 3, 2023
Validation of the Observer-Reported Communication Ability (ORCA) measure for individuals with Rett syndromeBryce B Reeve, Nicole Lucas, Dandan Chen, et al.
Journal of Child Neurology|August 11, 2021
Content Validation of Clinician-Reported Items for a Severity Measure for CDKL5 Deficiency DisorderJacinta Saldaris, Judith Weisenberg, Elia Pestana-Knight, et al.
Pageof 16

Showing results (101-110 of 156) with videos related to

Sort By:
Pageof 16
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 22, 2026
Therapeutic suppression of Tubb4a rescues H-ABC leukodystrophySunetra Sase, Julia L Hacker, Prabhat R Napit, et al.
Epilepsia|November 11, 2023
Long-term treatment with ganaxolone for seizures associated with cyclin-dependent kinase-like 5 deficiency disorder: Two-year open-label extension follow-upHeather E Olson, Sam Amin, Nadia Bahi-Buisson, et al.
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|July 4, 2024
Modification of a parent-report sleep scale for individuals with CDKL5 deficiency disorder: a psychometric studyJacinta M Saldaris, Scott Demarest, Peter Jacoby, et al.
Epilepsy Research|April 26, 2019
Long-term safety and efficacy of cannabidiol in children and adults with treatment resistant Lennox-Gastaut syndrome or Dravet syndrome: Expanded access program resultsLinda C Laux, E Martina Bebin, Daniel Checketts, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|September 9, 2025
Parent/caregiver perspectives of meaningful improvement in functional domains for people with CDKL5 deficiency disorder: a mixed-methods studyJessica Keeley, Zoe Skoda, Karen Utley, et al.
Brain and Behavior|November 14, 2025
Beyond Seizures as an Outcome Measure: A Global Severity Scoring System for CDKL5 Deficiency DisorderPeter Jacoby, Eric D Marsh, Scott Demarest, et al.
Elife|February 18, 2026
Impaired excitability of fast-spiking neurons in a novel mouse model of <i>KCNC1</i> epileptic encephalopathyEric R Wengert, Sophie R Liebergall, Teresa Jimenez, et al.
American Journal of Medical Genetics. Part A|March 22, 2021
Understanding the phenotypic spectrum of ASXL-related disease: Ten cases and a review of the literatureVishnu Anand Cuddapah, Holly A Dubbs, Laura Adang, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|August 3, 2023
Validation of the Observer-Reported Communication Ability (ORCA) measure for individuals with Rett syndromeBryce B Reeve, Nicole Lucas, Dandan Chen, et al.
Journal of Child Neurology|August 11, 2021
Content Validation of Clinician-Reported Items for a Severity Measure for CDKL5 Deficiency DisorderJacinta Saldaris, Judith Weisenberg, Elia Pestana-Knight, et al.
Pageof 16